U.S. health officials said they will not compromise on coronavirus vaccine safety after AstraZeneca suspended global trials of its experimental vaccine due to an unexplained illness in a study participant in the UK
- The pause of AstraZeneca Plc’s coronavirus vaccine trials due to an unexplained illness in a study participant shows that safety of vaccines will not be compromised, the head of the National Institutes of Health told a U.S. Congress panel on Wednesday.
AstraZeneca said it had paused global trials, including large late-stage trials, of the experimental vaccine following the development to allow an independent committee to review safety data.“I want to address concerns about safety. This is foremost in our minds. We cannot compromise here,” said NIH’s Director Francis Collins at a hearing by the Senate Health, Education, Labor and Pensions Committee.
The halt was the “best sort of cautious approach to quickly stop and look and see if there’s any other evidence to be concerned about,” Collins added. Also on Wednesday, the U.S. surgeon general Jerome Adams said at the hearing that the U.S. health department had issued guidance that would allow state-licensed pharmacists to administer coronavirus vaccines once they are available.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Halted coronavirus vaccine study shows 'no compromises' on safety, NIH saysAstraZeneca's suspension of testing of its coronavirus vaccine while it investigates an illness shows there will be 'no compromises' on safety, the NIH chief said.
Weiterlesen »
Halted coronavirus vaccine study shows 'no compromises' on safety, NIH saysAstraZeneca's suspension of testing of its coronavirus vaccine while it investigates an illness shows there will be 'no compromises' on safety, the NIH chief said.
Weiterlesen »
9 Companies Pledge Not To Submit Coronavirus Vaccine To FDA Until It's Proved SafeTo reassure the public, nine companies issued a joint statement Tuesday saying they won't seek government approval for their coronavirus vaccines until full safety and effectiveness data are in hand.
Weiterlesen »
Pause in AstraZeneca vaccine trial not necessarily a setback, says UK health ministerBritain's Health Secretary Matt Hancock said on Wednesday that AstraZeneca's decision to pause its coronavirus vaccine trials was a challenge but would not necessarily set back efforts to develop a vaccine.
Weiterlesen »